Reactivations of cytomegalovirus, human herpes virus 6, and Epstein-Barr virus differ with respect to risk factors and clinical outcome after hematopoietic stem cell transplantation

Transplantation Proceedings

Volumn 42, Issue 8, 2010, Pages 3273-3276

  Jaskula, E ^a   Dlubek, D ^a,b   Sedzimirska, M ^b   Duda, D ^b   Tarnowska, A ^b   Lange, A ^a,b  

^a INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

^b National Bone Marrow Donor Registry   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ACUTE GRAFT VERSUS HOST DISEASE; ADOLESCENT; ADULT; ARTICLE; BACTERIAL PNEUMONIA; CYTOMEGALOVIRUS; ENCEPHALITIS; EPSTEIN BARR VIRUS; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 6; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK FACTOR; TREATMENT OUTCOME; VIRUS DETECTION; VIRUS REACTIVATION;

CYTOMEGALOVIRUS; DNA, VIRAL; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HERPESVIRUS 4, HUMAN; HERPESVIRUS 6, HUMAN; HUMANS; MALE; POLYMERASE CHAIN REACTION; RISK FACTORS; TREATMENT OUTCOME; VIRUS ACTIVATION;

EID: 77958541970     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2010.07.027     Document Type: Article

References (19)

1. R. Parody, R. Martino, and Rovira Severe infections after unrelated donor allogeneic hematopoietic stem cell transplantation in adults: comparison of cord blood transplantation with peripheral blood and bone marrow transplantation Biol Blood Marrow Transplant 12 2006 734
2. M. Boeckh, W. Leisenring, and S.R. Riddell Late cytomegalovirus disease and mortality in recipients of allogeneic hematopoietic stem cell transplants: importance of viral load and T-cell immunity Blood 101 2003 407
3. M. Boeckh, W.G. Nichols, and G. Papanicolaou Cytomegalovirus in hematopoietic stem cell transplant recipients: current status, known challenges, and future strategies Biol Blood Marrow Transplant 9 2003 543
4. J. Styczynski, H. Einsele, and L. Gil Outcome of treatment of Epstein-Barr virusrelated post-transplant lymphoproliferative disorder in hematopoietic stem cell recipients: a comprehensive review of reported cases Transpl Infect Dis 11 2009 383
5. P. Comoli, S. Basso, and M. Zecca Preemptive therapy of EBV-related lymphoproliferative disease after pediatric haploidentical stem cell transplantation Am J Transplant 7 2007 1648
6. M.C. Chamberlain, and S. Chowdhary Post-transplant acute limbic encephalitis: clinical features and relationship to HHV6 Neurology 70 2008 491
7. H. Kimura, M. Morita, and Y. Yabuta Quantitative analysis of Epstein-Barr virus load by using a real-time PCR assay J Clin Microbiol 37 1999 132
8. U. Machida, M. Kami, and T. Fukui Real-time automated PCR for early diagnosis and monitoring of cytomegalovirus infection after bone marrow transplantation J Clin Microbiol 38 2000 2536
9. G. Locatelli, F. Santoro, and F. Veglia Real-time quantitative PCR for human herpesvirus 6 DNA J Clin Microbiol 38 2000 4042
10. D. Yahav, A. Gafter-Gvili, and E. Muchtar Antiviral prophylaxis in haematological patients: systematic review and meta-analysis Eur J Cancer 45 2009 3131
11. R. Lugert, U. Reichard, and F.T. Hufert Comparison between pp65 antigenemia assay and quantitative real-time polymerase chain reaction for detection of active cytomegalovirus infection in routine diagnostics Diagn Microbiol Infect Dis 65 2009 192
12. C. Gimeno, C. Solano, and J.C. Latorre Quantification of DNA in plasma by an automated real-time PCR assay (cytomegalovirus PCR kit) for surveillance of active cytomegalovirus infection and guidance of preemptive therapy for allogeneic hematopoietic stem cell transplant recipients J Clin Microbiol 46 2008 3311
13. E. Jaskula, D. Dlubek, and D. Duda Interferon gamma 13-CA-repeat homozygous genotype and a low proportion of CD4(+) lymphocytes are independent risk factors for cytomegalovirus reactivation with a high number of copies in hematopoietic stem cell transplantation recipients Biol Blood Marrow Transplant 15 2009 1296
14. M. Boeckh, H.W. Kim, and M.E. Flowers Long-term acyclovir for prevention of varicella zoster virus disease after allogeneic hematopoietic cell transplantationa randomized double-blind placebo-controlled study Blood 107 2006 1800
15. W. Miller, P. Flynn, and J. McCullough Cytomegalovirus infection after bone marrow transplantation: an association with acute graft-v-host disease Blood 67 1986 1162
16. P. Ljungman, L. Perez-Bercoff, and J. Jonsson Risk factors for the development of cytomegalovirus disease after allogeneic stem cell transplantation Haematologica 91 2006 78
17. A. Bjorklund, J. Aschan, and M. Labopin Risk factors for fatal infectious complications developing late after allogeneic stem cell transplantation Bone Marrow Transplant 40 2007 1055
18. W.W. Seeley, F.M. Marty, and T.M. Holmes Post-transplant acute limbic encephalitis: clinical features and relationship to HHV6 Neurology 69 2007 156
19. S. Kremer, J.F. Matern, and K. Bilger EBV limbic encephalitis after allogenic hematopoietic stem cell transplantation J Neuroradiol 2009